MedDataX Logo

Association Between Intake of Psychotropic Medications and Risk of Falls in Older Adults

NCT ID: NCT07112573

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

398 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess the association between intake of psychotropic medications and increased risk of falls in older adults discharged from Ain Shams University Geriatric Hospital as a primary outcome and incident fractures that may occur as a secondary outcome of such fall.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to assess the association between intake of psychotropic medications and increased risk of falls in older adults discharged from Ain Shams University Geriatric Hospital as a primary outcome and incident fractures that may occur as a secondary outcome of such fall. A prospective cohort study will be conducted. Older adults both males and females who were admitted to Ain Shams University, Geriatric Hospital will be included in this study with exclusion to patients with malignancy and bedridden patients. Baseline data will be collected retrospectively from the medical records of the patients admitted to Ain Shams University Geriatric Hospital from July 2024 till June 2025. Data include socio-demographic data, drug history, compliance on medications which will be assessed by Hill-Bone Medication Adherence Scale, history of falls, cognitive, psychological, nutritional and functional assessment and labs. Then follow up participants after 1 year after discharge from hospital through telephone call for occurrence of falls.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Falls (Accidents) in Old Age Psychotropic Drugs

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients (males and females) aged ≥ 60 years old patients who accept to participate in the study

Exclusion Criteria

* Patients with malignancy Bedridden patients
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams University

Cairo, Abbassia, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mariam Yasser Mohamed Safwat

Role: CONTACT

Phone: +0201028018042

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mariam Yasser Mohamed Safwat, M.B.B.CH., M.Sc.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMASU MD 139/2025

Identifier Type: -

Identifier Source: org_study_id